Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Biota Pharmaceuticals Inc    NABI

SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Operates as an anti-infective drug development company

Aviragen Therapeutics, Inc. engages in the discovery and development of direct-acting antivirals to treat infections.

Its product candidates include vapendavir, an oral treatment for human rhinovirus infections in moderate-to-severe asthmatics; BTA074, a topical antiviral treatment for genital warts caused by human papillomavirus types 6 & 11; BTA585, an oral fusion protein inhibitor for the treatment of RSV-A and RSV-B infections; and laninamivir octanoate, a one-time, inhaled treatment for influenza A and B infections.

The company was founded on November 8, 2012 and is headquartered in Alpharetta, GA.
Managers
NameAgeSinceTitle
Joseph M. Patti, PhD532012President, CEO & Executive Director
Russell H. Plumb MBA, CPA582012Executive Chairman
Mark P. Colonnese, MBA612015Chief Financial Officer & Executive Vice President
Anna Novotney-Barry-2013Vice President-Clinical Development
John H. Vernachio, PhD-2014Vice President-Preclinical Development
Geoffrey F. Cox, PhD732012Independent Non-Executive Director
Anne M. VanLent692013Lead Independent Non-Executive Director
Michael R. Dougherty592013Independent Non-Executive Director
John P. Richard, MBA592013Independent Non-Executive Director
Armando Anido, MBA592015Independent Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 38,649,237 38,192,309 98.8% 0 0.0% 98.8%
Shareholders
NameEquities%
East Hill Management Co. LLC 3,068,358 7.94%
Krensavage Asset Management LLC 2,836,326 7.34%
SC Fund Management LLC 1,972,632 5.10%
Armistice Capital LLC 1,122,829 2.91%
Renaissance Technologies LLC 1,058,103 2.74%
Fidelity Management & Research Co. 1,005,345 2.60%
The Vanguard Group, Inc. 997,897 2.58%
BlackRock Fund Advisors 474,756 1.23%
Landon Thomas Clay 413,259 1.07%
Gabelli & Co. Investment Advisers, Inc. 224,477 0.58%
Company contact information
Aviragen Therapeutics, Inc.
2500 Northwinds Parkway
Suite 100
Alpharetta, GA 30009

Phone : +1.678.221.3343
Web : www.aviragen.com
Sector Bio Therapeutic Drugs
1st jan.Capitalization (M$)
BIOTA PHARMACEUTICALS INC27
GILEAD SCIENCES11.65%104 409
REGENERON PHARMACEUTICALS20.67%47 756
VERTEX PHARMACEUTICALS107.56%39 003
ACTELION23.24%29 757
GENMAB22.08%13 881
EXELIXIS, INC.66.06%8 529
BLUEBIRD BIO INC113.45%6 533
TESARO INC-8.54%6 519
BIOVERATIV INC0.00%6 400
TONGHUA DONGBAO PHARMACEUTICAL CO., LTD.1.14%5 786
NEUROCRINE BIOSCIENCES, INC.60.59%5 394
JUNO THERAPEUTICS INC127.59%4 788
CLOVIS ONCOLOGY INC89.71%4 134
BEIGENE LTD (ADR)210.80%3 972
HUALAN BIOLOGICAL ENGINEERING INC--.--%3 957
PEPTIDREAM INC-42.52%3 816
BIOCON LTD17.29%3 467
AGIOS PHARMACEUTICALS INC70.98%3 442
SAREPTA THERAPEUTICS INC84.36%3 264
AVEXIS INC118.71%3 257
© 2017 People , Fundamentals and Ownership